LLDT-8 ameliorates experimental autoimmune encephalomyelitis by mediating macrophage functions in the priming stage

Eur J Pharmacol. 2024 Jan 5:962:176201. doi: 10.1016/j.ejphar.2023.176201. Epub 2023 Nov 19.

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease in the central nervous system caused by T cell activation mediated by peripheral macrophages, resulting in severe neurological deficits and disability. Due to the currently limited and expensive treatments for MS, we here introduce an economic Chinese medicine extract, (5R)-5-Hydroxytriptolide (LLDT-8), which shows low toxicity and high immunosuppressive activity. We used the widely accepted mouse model of MS, experimental autoimmune encephalomyelitis (EAE), to examine the immunosuppressive effect of LLDT-8 in vivo. Through the RNA-sequence analysis of peripheral macrophages in EAE mice, we discovered that LLDT-8 alleviates the symptoms of EAE by inhibiting the proinflammatory effect of macrophages, thereby blocking the activation and proliferation of T cells. In all, we found that LLDT-8 could be a potential treatment for MS.

Keywords: EAE; LLDT-8; MS; Macrophage; T cell.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Encephalomyelitis, Autoimmune, Experimental* / drug therapy
  • Lymphocyte Activation
  • Macrophages
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes